Furthermore, the specific analysis of database samples comparing pure DCIS patients to IDC patients strongly confirmed that SEMA3F, NRP1 and NRP2 were upregulated in the invasive stage and that their expression was correlated with TGFβ pathway stimulation and with increased activation of MMPs, a trend highly related to EMT. This evidence concerns the gene SEMA3F and ductal breast carcinoma in situ.